Bank of America’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-922,172
| Closed | -$8.67M | – | 7578 |
|
|
2020
Q3 | $8.67M | Buy |
922,172
+88,280
| +11% | +$839K | ﹤0.01% | 2401 |
|
|
2020
Q2 | $6.38M | Buy |
833,892
+520,830
| +166% | +$3.99M | ﹤0.01% | 2641 |
|
|
2020
Q1 | $1.94M | Sell |
313,062
-306,443
| -49% | -$2.7M | ﹤0.01% | 3507 |
|
|
2019
Q4 | $7.54M | Buy |
619,505
+570,734
| +1,170% | +$6.24M | ﹤0.01% | 2837 |
|
|
2019
Q3 | $563K | Sell |
48,771
-63,712
| -57% | -$671K | ﹤0.01% | 4990 |
|
|
2019
Q2 | $1.12M | Sell |
112,483
-8,338
| -7% | -$90K | ﹤0.01% | 4484 |
|
|
2019
Q1 | $1.56M | Buy |
120,821
+94,121
| +353% | +$1.4M | ﹤0.01% | 4188 |
|
|
2018
Q4 | $404K | Buy |
26,700
+14,764
| +124% | +$281K | ﹤0.01% | 5077 |
|
|
2018
Q3 | $239K | Sell |
11,936
-92,689
| -89% | -$2.11M | ﹤0.01% | 5390 |
|
|
2018
Q2 | $2.04M | Buy |
104,625
+67,552
| +182% | +$1.49M | ﹤0.01% | 3963 |
|
|
2018
Q1 | $748K | Sell |
37,073
-5,140
| -12% | -$86.9K | ﹤0.01% | 4572 |
|
|
2017
Q4 | $559K | Sell |
42,213
-28,270
| -40% | -$426K | ﹤0.01% | 4874 |
|
|
2017
Q3 | $1.3M | Buy |
70,483
+9,094
| +15% | +$169K | ﹤0.01% | 4324 |
|
|
2017
Q2 | $1.13M | Sell |
61,389
-1,670
| -3% | -$33.1K | ﹤0.01% | 4343 |
|
|
2017
Q1 | $1.42M | Sell |
63,059
-54,134
| -46% | -$1.3M | ﹤0.01% | 4171 |
|
|
2016
Q4 | $4.08M | Buy |
117,193
+23,614
| +25% | +$705K | ﹤0.01% | 3126 |
|
|
2016
Q3 | $2.29M | Sell |
93,579
-1,786
| -2% | -$44.6K | ﹤0.01% | 3532 |
|
|
2016
Q2 | $2.28M | Sell |
95,365
-23,694
| -20% | -$543K | ﹤0.01% | 3522 |
|
|
2016
Q1 | $2.79M | Buy |
119,059
+5,154
| +5% | +$122K | ﹤0.01% | 3290 |
|
|
2015
Q4 | $3.44M | Sell |
113,905
-39,821
| -26% | -$1.29M | ﹤0.01% | 3308 |
|
|
2015
Q3 | $6.11M | Buy |
153,726
+141,628
| +1,171% | +$8.79M | ﹤0.01% | 2692 |
|
|
2015
Q2 | $836K | Sell |
12,098
-14,643
| -55% | -$921K | ﹤0.01% | 4255 |
|
|
2015
Q1 | $1.46M | Buy |
26,741
+19,196
| +254% | +$915K | ﹤0.01% | 3488 |
|
|
2014
Q4 | $322K | Buy |
7,545
+6,782
| +889% | +$245K | ﹤0.01% | 4976 |
|
|
2014
Q3 | $24K | Sell |
763
-5,535
| -88% | -$118K | ﹤0.01% | 6953 |
|
|
2014
Q2 | $131K | Buy |
6,298
+6,243
| +11,351% | +$115K | ﹤0.01% | 5915 |
|
|
2014
Q1 | $1K | Sell |
55
-7,379
| -99% | -$157K | ﹤0.01% | 7667 |
|
|
2013
Q4 | $180K | Sell |
7,434
-3,116
| -30% | -$73.3K | ﹤0.01% | 5687 |
|
|
2013
Q3 | $227K | Sell |
10,550
-8,202
| -44% | -$194K | ﹤0.01% | 5354 |
|
|
2013
Q2 | $417K | Buy |
+18,752
| New | +$413K | ﹤0.01% | 4920 |
|
Bank of America's AMAG Position: Q4 2020 in Review
Bank of America sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 922,172 shares — an estimated $8.67M sold.
Bank of America first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $8.67M in Q3 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Bank of America reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Bank of America sold 922,172 AMAG Pharmaceuticals shares in Q4 2020, an estimated $8.67M.
- Bank of America first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Bank of America's AMAG Pharmaceuticals position peaked at $8.67M in Q3 2020.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.